ATX 0.00% 12.0¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-31

  1. 67 Posts.
    lightbulb Created with Sketch. 4
    Thanks for sharing and a lot of detail in that 35min.
    He did mention they are talking to potential regional pharma to support in the shorter term.
    Today's video was very short and straight to the point but at least Dr Burns is trying to get the word out and looking for partners and investors.
    Many opportunities as FAK inhibitors can be used on their own on non oncology however they will most probably work better when combined.

 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
0.000(0.00%)
Mkt cap ! $32.97M
Open High Low Value Volume
12.3¢ 12.3¢ 12.0¢ $410 3.354K

Buyers (Bids)

No. Vol. Price($)
4 59269 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 6301 1
View Market Depth
Last trade - 15.57pm 30/08/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.